Literature DB >> 3484823

High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells.

J C Gasson, S E Kaufman, R H Weisbart, M Tomonaga, D W Golde.   

Abstract

Purified natural and biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulate colony formation by myeloid progenitor cells and enhance the function of mature neutrophils. Both of these actions occur at concentrations between 1 and 100 pM, with half-maximal stimulation at 10-20 pM. We have examined specific binding of 125I-labeled GM-CSF to responsive target cells in this range of concentrations. The results show a low number (50-250) of high-affinity (15-30 pM) binding sites on GM-CSF-responsive leukemic cells (KG-1, HL-60), as well as on peripheral blood neutrophils from normal donors. This high-affinity binding component was absent from unresponsive cell lines (KG-1a, K562). These results suggest that this binding site mediates the biological activities of GM-CSF on both proliferation and function of myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484823      PMCID: PMC322925          DOI: 10.1073/pnas.83.3.669

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Scatchard plots: common errors in correction and interpretation.

Authors:  G C Chamness; W L McGuire
Journal:  Steroids       Date:  1975-10       Impact factor: 2.668

2.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

3.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

4.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

5.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

Authors:  M A Vadas; N A Nicola; D Metcalf
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

6.  Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells.

Authors:  R H Weisbart; A J Lusis; G Chan; R Billing; R F Ashman; D W Golde
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  Iodination of biological samples without loss of functional activity.

Authors:  F Tejedor; J P Ballesta
Journal:  Anal Biochem       Date:  1982-11-15       Impact factor: 3.365

8.  An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).

Authors:  H P Koeffler; R Billing; A J Lusis; R Sparkes; D W Golde
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

9.  Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues.

Authors:  P V Byrne; L J Guilbert; E R Stanley
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

10.  Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells.

Authors:  L J Guilbert; E R Stanley
Journal:  J Cell Biol       Date:  1980-04       Impact factor: 10.539

View more
  37 in total

1.  Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  D E Williams; D C Bicknell; L S Park; J E Straneva; S Cooper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.

Authors:  M A Arnaout; E A Wang; S C Clark; C A Sieff
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

4.  Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling.

Authors:  Garrett J DeYulia; Juan M Cárcamo; Oriana Bórquez-Ojeda; Christopher C Shelton; David W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

5.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

7.  Effects of cell differentiation on the synthesis of the third and fourth component of complement (C3, C4) by the human monocytic cell line U937.

Authors:  H Tsukamoto; K Nagasawa; Y Ueda; T Mayumi; I Furugo; T Tsuru; Y Niho
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

8.  Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells.

Authors:  M L Heaney; J C Vera; M A Raines; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.

Authors:  A W Nienhuis; R E Donahue; S Karlsson; S C Clark; B Agricola; N Antinoff; J E Pierce; P Turner; W F Anderson; D G Nathan
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.